Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Prostate cancer, Secondary cancers
Closed
Phase 3
This trial is for people with metastatic castration resistant prostate cancer (mCRPC). This means that the cancer:
has spread to other parts of the body
got worse despite having hormone treatment
It is for people who are going to have treatment for metastatic resistant prostate cancer for the first time.
Recruitment start: 1 December 2018
Recruitment end: 31 January 2020
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Noel Clarke
AstraZeneca
Last reviewed: 03 Feb 2020
CRUK internal database number: 15962